Advertisement

Topics

ConvaTec 2017 profits fall on supply issues and lower sales of new products

03:13 EST 15 Feb 2018 | Proactive Investors

ConvaTec Group expects organic revenue growth to accelerate in 2018

Original Article: ConvaTec 2017 profits fall on supply issues and lower sales of new products

NEXT ARTICLE

More From BioPortfolio on "ConvaTec 2017 profits fall on supply issues and lower sales of new products"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...